ArticleJAPhA practice innovations2026
Exploratory analysis of pharmacist involvement in motivational interviewing intervention for patients with prescription opioid misuse behaviors.
Article in JAPhA practice innovations, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Barriers and facilitators to the implementation of screening and intervention for co-use of opioid medications and alcohol among community pharmacy patients.Journal of substance use and addiction treatment · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Background: Community pharmacists are an underutilized resource to address opioid medication misuse (OMM) among patients. It is unknown in the field if specific training in high-fidelity motivational interviewing (MI) targeting OMM can be integrated into pharmacist-led medication therapy management (MTM) sessions. Objectives: Present and analyze displayed pharmacist MI skills during 47 pharmacist-led medication therapy management sessions, completed as part of the larger parent Healthy Opioid Prescription Engagement 2.0 study. Methods: Design/participants: We conducted an exploratory analysis utilizing recordings from three pharmacist interventionists who received MI training and subsequent supervision sessions as part of a behavioral health randomized clinical trial targeting OMM using MTM. Procedure: 20-minute session segments (N = 47) employing MI skills were coded using the MI Treatment Integrity Coding Manual 4.2.1. Assessments/analyses: Frequencies/percentages and means described intervention recipient demographics and fidelity of pharmacist MI skills-global scores, reflections, and MI behavior counts. Results: Intervention recipients were approximately 50 years old, had more than or equal to moderate severity depression (51.1%), and/or opioid use disorder (29.8%). Regarding pharmacist performance, relational/technical global scores averaged 3.6 and 3.8, respectively, reaching competency. Complex reflections averaged 60.2%, reaching proficiency. MI adherent counts averaged 11 times greater than non-adherent counts (4.4, 0.4) and zero confrontations were coded, meaning pharmacists avoided stigmatizing behaviors while delivering high fidelity MI skills during MTM sessions to address opioid medication misuse. Conclusion: Pharmacists delivering MTM sessions have the potential to effectively address opioid-related risk during MTM sessions by integrating high-fidelity MI skills following structured training/supervision.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.